SALT LAKE CITY, Oct. 13, 2015 /PRNewswire-iReach/ — This week, Juneau Biosciences, LLC presented new discoveries concerning the genetics of endometriosis at the American Society of Human Genetics meeting in Baltimore, MD. Dr. Kenneth Ward, M.D., Juneau’s founder and CEO, described the first “major gene” effect associated with endometriosis.  Juneau scientists found damaging mutations in the NLRP2 gene in one out of every eleven endometriosis patients studied. These mutations appear to increase the risk of developing endometriosis by as much as ten-fold.

Read More